Phosphate-binding polymers for oral administration

Details Phosphate-binding polymers for oral administration Phosphate-binding polymers for oral administration

2006-03-21

2006-03-21

Page, Thurman K. (Department: 1615)

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Ion exchange resin

C424S078010, C424S078110, C424S078120, C424S078080, C424S078160

Reexamination Certificate

active

07014846

ABSTRACT:
Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.

REFERENCES:
patent: 2456428 (1948-12-01), Parker
patent: 3104205 (1963-09-01), Hainer et al.
patent: 3308020 (1967-03-01), Tennant et al.
patent: 3332841 (1967-07-01), Ainsworth et al.
patent: 3624209 (1971-11-01), Granatek et al.
patent: 3980770 (1976-09-01), Ingelman et al.
patent: 4071478 (1978-01-01), Shen et al.
patent: 4143130 (1979-03-01), Imondi et al.
patent: 4181718 (1980-01-01), Mason et al.
patent: 4183918 (1980-01-01), Asher et al.
patent: 4205064 (1980-05-01), Wagner et al.
patent: 4247393 (1981-01-01), Wallace
patent: 4504640 (1985-03-01), Harada et al.
patent: 4605701 (1986-08-01), Harada et al.
patent: 4631305 (1986-12-01), Guyer et al.
patent: 4895621 (1990-01-01), Hassler
patent: 5053423 (1991-10-01), Liu
patent: 5055197 (1991-10-01), Albright et al.
patent: 5108767 (1992-04-01), Mulchandani et al.
patent: 5302531 (1994-04-01), Bauer
patent: 5374422 (1994-12-01), St. Pierre et al.
patent: 5414068 (1995-05-01), Bliem et al.
patent: 5428112 (1995-06-01), Ahlers et al.
patent: 5430110 (1995-07-01), Ahlers et al.
patent: 5462730 (1995-10-01), McTaggart et al.
patent: 5487888 (1996-01-01), Mandeville et al.
patent: 5496545 (1996-03-01), Holmes-Farley et al.
patent: 5667775 (1997-09-01), Holmes-Farley et al.
patent: 5702696 (1997-12-01), Mandeville et al.
patent: 5985938 (1999-11-01), Holmes-Farley et al.
patent: 6083495 (2000-07-01), Holmes-Farley et al.
patent: 6177478 (2001-01-01), Holmes-Farley et al.
patent: 6274713 (2001-08-01), Sieving et al.
patent: 6281252 (2001-08-01), Holmes-Farley et al.
patent: 6500527 (2002-12-01), Miller
patent: 6509013 (2003-01-01), Holmes-Farley et al.
patent: 6566407 (2003-05-01), Holmes-Farley et al.
patent: 6605270 (2003-08-01), Mandeville et al.
patent: 2003/0133902 (2003-07-01), Holmes-Farley et al.
patent: 480922 (1977-02-01), None
patent: 689797 (1998-04-01), None
patent: 0 162 388 (1985-11-01), None
patent: 0 375 350 (1990-06-01), None
patent: 0 379 161 (1990-07-01), None
patent: 0 449 151 (1991-10-01), None
patent: 0 534 304 (1993-03-01), None
patent: 0 605 757 (1994-07-01), None
patent: 2 217 010 (1974-09-01), None
patent: 2 232 563 (1975-01-01), None
patent: 929391 (1963-06-01), None
patent: 1238597 (1971-07-01), None
patent: 2 036 048 (1978-11-01), None
patent: 2391730 (1978-12-01), None
patent: 1573487 (1980-08-01), None
patent: 2 090 605 (1982-07-01), None
patent: 2276170 (1994-09-01), None
patent: 50-34095 (1975-02-01), None
patent: 58079022 (1983-05-01), None
patent: 62-132830 (1987-06-01), None
patent: 4-503962 (1990-03-01), None
patent: 5-244915 (1993-09-01), None
patent: 6-321786 (1994-11-01), None
patent: 7401543 (1974-08-01), None
patent: 7603653 (1976-10-01), None
patent: 1808015 (1993-04-01), None
patent: WO 90/02148 (1990-03-01), None
patent: WO 92/10522 (1992-06-01), None
patent: WO 93/05793 (1993-01-01), None
patent: WO 94/19379 (1994-01-01), None
patent: WO 94/04596 (1994-03-01), None
patent: WO 94/27620 (1994-12-01), None
patent: WO 94/27621 (1994-12-01), None
patent: WO 95/05184 (1995-02-01), None
patent: WO 96/21454 (1996-07-01), None
patent: WO 96/25440 (1996-08-01), None
McGary, T.J., et al., “Polycation As an Alternative Osmotic Agent and Phosphate Binder in Peritoneal Dialysis,”Uremia Investigation, 8 (2):79-84, (1984-1985).
Physicians' Desk Reference, Consult 1992 Supplements for Revisions “Phoslo®”, Calcium Acetate Tablets.
Physicians' Desk Reference, Consult 1992 Supplements for Revisions “Amphojel®”, suspension Tablets.
Burt et al., “Ion-Exchange Resins as Potential Phosphate-Binding Agents for Renal Failure Patients: Effect of the Physicochemical Properties of Resins on Phosphate and Bile Salt Binding,”Journal of Pharmaceutical Sciences, 76(5):379-383 (1987).
Delmez, James A. et al., “Hyperphosphatemia: Its Consequences and Treatment in Patients with Chronic Renal Disease,”American Journal of Kidney Diseases, XIX(4):303-317 (1992).
Emmett, Michael et al., “Calcium Acetate Control of Serum Phosphorus in Hemodialysis Patients,”American Journal of Kidney Diseases, XVII(5):544-550 (1991).
Ghosh, J.P. et al., “Preparation and Properties of a New Chelating Resin Containing 2-Nitroso-1-naphthol,”Talanta, 28:957-959 (1981).
Mai, Martin L. et al., “Calcium acetate, an effective phosphorus binder in patients with renal failure,”Kidney International, 36:690-695 (1989).
Munson, Paul L., “Studies on the Role of the Parathyroids in Calcium and Phosphorous Metabolism,”Annals New York Academy of Sciences, pp. 776-795 (Jun. 1993).
Salusky, I.B. et al., “Aluminum Accumulation During Treatment with Aluminum Hydroxide and Dialysis in Children and Young Adults with Chronic Renal Disease,”The New England Journal of Medicine, 324(8):537-531 (1991).
Slatopolsky, Eduardo et al., “Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis,”The New England Journal of Medicine, 315(3):157-161 (1986).
Warshawsky, A., in Ion Exchange and Sorption Processes in Hydrometallurgy Critical Reports on Applied Chemistry, vol. 15, Chapter 4:Chelating ion exchangers, pp. 166-225 M. Streat & D. Naden (Eds.), John Wiley & Sons, (1987).
Winston, Anthony and Kirchner, Darrell, “Hydroxamic Acid Polymers. Effect of Structure of the Selective Chelation of Iron in Water,”Macromolecules, 11(3):597-603 (1978).
Winston, Anthony and McLaughline, Glenn R., “Hydroxamic Acid Polymers. II. Design of a Polymeric Chelating Agent for Iron,”Journal of Polymer Science, 14:2155-2165 (1976).

Affiliated with

Also associated with

Rating

Phosphate-binding polymers for oral administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphate-binding polymers for oral administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphate-binding polymers for oral administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3603612